跳至主要内容
临床试验/NCT03084185
NCT03084185Unknown不适用

Evaluation of the Role of Plasma Biomarkers for Portal Hypertension Progression and Oxidative Damage in Decompensation of Cirrhotic Patient.

University of Modena and Reggio Emilia1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Identification of predictive biomarkers for the deficit development in patients with compensated cirrhosis.

研究概览

简要总结

This is a single-center and prospective study to identify specific biomarker in order to predict development of decompensation in cirrhotic patients.

The duration of the study is 36 months and it provides a cohort of 200 patients.

详细描述

At screening, patient will have taken blood samples and performed hepatic vein pressure gradient.

After randomization, patient will be seen at follow up every 3 months to do blood sample and every 12 months to undergo hepatic vein pressure gradient , according to the guidelines.

In addition, metabolomics analysis will be performed at screening and every 3 months. The results will be analyzed in relation to emergence of decompensation during follow up period, in order to identify specific metabolomics characteristics that may be able to predict decompensation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of liver cirrhosis
  • Aged between 18 and 75 years
  • Obtaining written informed consent
  • Absence of exclusion criteria

排除标准

  • Diagnosis of hepatocellular carcinoma
  • Presence of portal vein thrombosis
  • Liver transplantation

结局指标

主要结局

Identification of predictive biomarkers for the deficit development in patients with compensated cirrhosis.

时间窗: December 2018

Patients will be subject to blood sample periodically and following exams will be made: * Chemistry and hematology to define liver function * Intestinal Fatty Acid Binding Protein * 16S, ribosomal deoxyribonucleic acid * Cluster of differentiation 14 * Interleukin 6 * Asymmetrical dimethylarginine * Tissue factor According to current guidelines, patients will be submitted to: * Hepatic vein pressure gradient AND combined right heart catheterization * Liver elastography

次要结局

  • Finding of serum metabolomic features of cirrhotic patients.(December 2018)

研究者

发起方
University of Modena and Reggio Emilia
申办方类型
Other
责任方
Principal Investigator
主要研究者

ERICA VILLA

Professor

University of Modena and Reggio Emilia

研究点 (1)

Loading locations...

相似试验